Barry D. Quart, Director at Kiniksa Pharmaceuticals International, plc (KNSA), sold 2,800 shares at $45.00 ($126K) on 2026-02-12, disclosed to the SEC on 2026-02-12.
Scheduled sale ($126k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.00 | 110 | $5K | 3.9% |
| 2 | $45.00 | 2,690 | $121K | 96.1% |
| Total | $45.00 avg | 2,800 | $126K | 100% |
| Filing → |
| KNSA | SELL | 2026-02-04 | $722K | — | Filing → |
| KNSA | SELL | 2025-12-17 | $1.7M | — | Filing → |
| KNSA | SELL | 2025-06-11 | $1.5M | — | Filing → |